Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

IRON Disc Medicine Inc

29,79

0,79 (2,72%)

04 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Disc Medicine (NASDAQ:IRON)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Disc Medicine Charts.

Disc Medicine (NASDAQ:IRON)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Disc Medicine Charts.

News Disc Medicine Inc

Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
Montag 1 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Donnerstag 21 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
Mittwoch 6 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 2 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 26 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
Montag 26 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
Dienstag 20 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Disc Medicine Inc News-Artikel

Invesco QQQ Trust Series 1

Deutsche Lufthansa

Financial Select Sector

JP Morgan Chase

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen